StockData
Dyadic International Inc logo

Dyadic International Inc (DYAI) stock

DYAINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/30
$0.32−0.00 (-1.25%)

Close on Nov 17, 2026Market cap $11.51MP/E –Yield –

Dyadic International r&d expenses

Research and development expenses are spending on new products and technology.

Dyadic International's R&D Expenses for the twelve months ending Sep 30, 2026 was $1.70M, down 24.3% year over year. For fiscal 2025 it was $2.15M, up 5.4% from the year before. The highest annual figure on record is $8.39M in fiscal 2021.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.15M+5.4%
FY2024Dec 31, 2024$2.04M-38.0%
FY2023Dec 31, 2023$3.30M-26.7%
FY2022Dec 31, 2022$4.50M-46.4%
FY2021Dec 31, 2021$8.39M+117.0%
FY2020Dec 31, 2020$3.87M+25.3%
FY2019Dec 31, 2019$3.09M+46.9%
FY2018Dec 31, 2018$2.10M+19.0%
FY2017Dec 31, 2017$1.77M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$429.95K-24.8%
Q2 FY2026Jun 30, 2026$332.62K-47.2%
Q1 FY2026Mar 31, 2026$476.07K-3.8%
Q4 FY2025Dec 31, 2025$458.44K-16.0%
Q3 FY2025Sep 30, 2025$571.87K+24.3%
Q2 FY2025Jun 30, 2025$629.38K+22.1%
Q1 FY2025Mar 31, 2025$494.98K-5.3%
Q4 FY2024Dec 31, 2024$545.66K-36.0%
Q3 FY2024Sep 30, 2024$460.24K-35.8%
Q2 FY2024Jun 30, 2024$515.63K-43.8%
Q1 FY2024Mar 31, 2024$522.72K-35.5%
Q4 FY2023Dec 31, 2023$852.80K+46.0%
Q3 FY2023Sep 30, 2023$716.35K-3.7%
Q2 FY2023Jun 30, 2023$917.55K-49.9%
Q1 FY2023Mar 31, 2023$810.57K-39.6%
Q4 FY2022Dec 31, 2022$584.12K-76.4%
Q3 FY2022Sep 30, 2022$743.59K-60.9%
Q2 FY2022Jun 30, 2022$1.83M-17.1%
Q1 FY2022Mar 31, 2022$1.34M-99.9%
Q4 FY2021Dec 31, 2021$2.47M+144.8%
Q3 FY2021Sep 30, 2021$1.90M+92.8%
Q2 FY2021Jun 30, 2021$2.21M+97.9%
Q1 FY2021Mar 31, 2021$1.81B+239239.6%
Q4 FY2020Dec 31, 2020$1.01M+37.4%
Q3 FY2020Sep 30, 2020$986.05K+17.2%
Q2 FY2020Jun 30, 2020$1.12M+36.4%
Q1 FY2020Mar 31, 2020$755.45K+9.1%
Q4 FY2019Dec 31, 2019$735.64K+64.6%
Q3 FY2019Sep 30, 2019$841.34K+76.5%
Q2 FY2019Jun 30, 2019$818.24K+36.1%
Q1 FY2019Mar 31, 2019$692.37K+20.0%
Q4 FY2018Dec 31, 2018$446.91K–
Q3 FY2018Sep 30, 2018$476.63K–
Q2 FY2018Jun 30, 2018$601.20K–
Q1 FY2018Mar 31, 2018$576.88K–

More Dyadic International figures

See a number that looks wrong?